US2021389316A1PendingUtilityA1
System and apparatus for point-of-care diagnostics
Est. expiryMar 1, 2032(~5.6 yrs left)· nominal 20-yr term from priority
G01N 33/54388G01N 33/54366G01N 21/8483G01N 21/6486B01L 2300/0825G01N 2201/12792B01L 9/52G01N 2201/12707B01L 2300/0816G01N 2469/10G01N 33/56944G01N 33/53G01N 21/6428G01N 33/56983G01N 2021/6439G01N 2333/11G01N 33/558
74
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A system comprised of an apparatus and a test device is described. The test device and the apparatus are designed to interact to determine the presence or absence of an analyte of interest in a sample placed on the test device.
Claims
exact text as granted — not AI-modifiedIt is claimed:
1 . A system, comprising:
an apparatus comprised of (i) a housing configured to receive a test device, wherein the test device comprises a reference line and an analyte-specific test line; (ii) an illumination source; (iii) a detector; and (iv) a processor comprising a software program for control of the illumination source and the detector; wherein signal data obtained by the detector in response to illumination of the test device by the illumination source is processed to: (a) generate a one-dimensional data array of values corresponding to signal data associated with the reference line and the analyte-specific test line, (b) evaluate data in the data array corresponding to signal data from the reference line, and (c) analyze signal data that corresponds to the analyte-specific test line to report a result regarding presence or absence of an analyte at the analyte-specific test line.
2 . The system of claim 1 , wherein the detector comprises a photodetector.
3 . The system of claim 1 , wherein the processor comprises a software program configured to direct analysis of data in the data array by calculating a first derivative of the data array to identify a minimum peak and a maximum peak corresponding to the reference line.
4 . The system of claim 1 , wherein the processor comprises a software program configured to direct analysis of data in the data array by calculating a first derivative of the data array to form a derivative data set, wherein a positive peak and a negative peak in the derivative data set indicate location of the reference line on the test device.
5 . The system of claim 1 , wherein the illumination source is a light emitting diode.
6 . The system of claim 5 , wherein the light emitting diode emits light at about 365 nm.
7 . The system of claim 1 , wherein the detector detects signal emitted from the test device during illumination by the illumination source.
8 . The system of claim 7 , wherein the emitted signal is emitted from a fluorescing lanthanide compound.
9 . The system of claim 8 , wherein the fluorescing lanthanide compound is chelated europium.
10 . The system of claim 9 , wherein the chelated europium is embedded in microparticles.
11 . A method for analyzing a test line and reference line of a test device, comprising:
inserting a test device comprising a reference line and an analyte-specific test line into an apparatus comprising an illumination source, a detector; and a processor comprising a software program for control of the illumination source and the photodetector and for processing data obtained from the photodetector; and processing data corresponding to signal emitted from the test device by generating a one-dimensional data array of values corresponding to signal associated with the reference line and the analyte-specific test line in response to illumination by the illumination source, and calculating a first derivative of the one-dimensional array to generate a derivative data set, wherein a peak in the derivative data set corresponds to data from the reference line or the control line.
12 . The method of claim 11 , wherein the test device is an immunoassay test device for detection of an analyte of interest.
13 . The method of claim 12 , wherein the analyte of interest is an infectious analyte.
14 . The method of claim 13 , wherein the infectious analyte is a virus or a bacteria.
15 . The method of claim 11 , wherein the reference line comprises antibodies for non-specific binding to immunoglobulins present in a sample, and based on its fluorescent signal communicates to the processor whether sufficient sample has reached the reference line.
16 . The method of claim 12 , wherein the test device comprises microparticles comprised of a fluorescing lanthanide compound and an antibody with binding specificity for the analyte of interest.Join the waitlist — get patent alerts
Track US2021389316A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.